Compare Piramal Healthcare with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DISHMAN PHARMA - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DISHMAN PHARMA PIRAMAL ENTERPRISES/
DISHMAN PHARMA
 
P/E (TTM) x 17.3 25.1 69.1% View Chart
P/BV x 1.1 3.3 32.9% View Chart
Dividend Yield % 1.6 0.7 242.3%  

Financials

 PIRAMAL ENTERPRISES   DISHMAN PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
DISHMAN PHARMA
Mar-16
PIRAMAL ENTERPRISES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,303374 882.1%   
Low Rs1,797129 1,393.9%   
Sales per share (Unadj.) Rs716.5197.8 362.2%  
Earnings per share (Unadj.) Rs79.721.2 375.9%  
Cash flow per share (Unadj.) Rs107.934.7 310.8%  
Dividends per share (Unadj.) Rs28.002.00 1,400.0%  
Dividend yield (eoy) %1.10.8 138.2%  
Book value per share (Unadj.) Rs1,477.5179.9 821.3%  
Shares outstanding (eoy) m184.4580.69 228.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.61.3 279.7%   
Avg P/E ratio x32.011.9 269.6%  
P/CF ratio (eoy) x23.67.2 326.0%  
Price / Book Value ratio x1.71.4 123.4%  
Dividend payout %35.19.4 372.5%   
Avg Mkt Cap Rs m470,29220,306 2,316.1%   
No. of employees `0007.80.8 943.3%   
Total wages/salary Rs m22,5045,355 420.2%   
Avg. sales/employee Rs Th16,899.419,252.7 87.8%   
Avg. wages/employee Rs Th2,877.76,459.5 44.5%   
Avg. net profit/employee Rs Th1,879.92,064.1 91.1%   
INCOME DATA
Net Sales Rs m132,15315,961 828.0%  
Other income Rs m3,128265 1,178.6%   
Total revenues Rs m135,28116,226 833.7%   
Gross profit Rs m66,2904,103 1,615.6%  
Depreciation Rs m5,2021,091 476.9%   
Interest Rs m44,097944 4,669.4%   
Profit before tax Rs m20,1192,334 862.1%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611624 1,380.9%   
Profit after tax Rs m14,7011,711 859.2%  
Gross profit margin %50.225.7 195.1%  
Effective tax rate %42.826.7 160.2%   
Net profit margin %11.110.7 103.8%  
BALANCE SHEET DATA
Current assets Rs m122,74211,018 1,114.0%   
Current liabilities Rs m310,8109,517 3,265.8%   
Net working cap to sales %-142.39.4 -1,513.3%  
Current ratio x0.41.2 34.1%  
Inventory Days Days23110 20.9%  
Debtors Days Days3935 111.5%  
Net fixed assets Rs m116,90416,304 717.0%   
Share capital Rs m369161 228.6%   
"Free" reserves Rs m272,16112,907 2,108.7%   
Net worth Rs m272,53014,516 1,877.5%   
Long term debt Rs m270,1964,189 6,449.5%   
Total assets Rs m856,26129,805 2,872.9%  
Interest coverage x1.53.5 42.0%   
Debt to equity ratio x1.00.3 343.5%  
Sales to assets ratio x0.20.5 28.8%   
Return on assets %6.98.9 77.1%  
Return on equity %5.411.8 45.8%  
Return on capital %12.417.5 70.9%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m15,2004,952 307.0%   
Fx outflow Rs m4,889697 701.6%   
Net fx Rs m10,3124,255 242.4%   
CASH FLOW
From Operations Rs m-115,9752,786 -4,162.2%  
From Investments Rs m-8,265-1,529 540.6%  
From Financial Activity Rs m107,525-941 -11,425.4%  
Net Cashflow Rs m-16,650316 -5,262.4%  

Share Holding

Indian Promoters % 52.9 61.4 86.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 3.7 108.1%  
FIIs % 26.6 12.7 209.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 22.1 74.7%  
Shareholders   93,274 46,261 201.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   BIOCON   CADILA HEALTHCARE  SUVEN LIFESCIENCES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 24, 2019 09:35 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - JUBILANT LIFE SCIENCES COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS